Nano Biotechnology Market to Expand at a Healthy Growth Rate During the Forecast Period (2020-27)
Market Scope
Market Research
Future (MRFR) believes that the Nano Biotechnology Market could capture a valuation of
around USD 9,500 Million by 2027. Moreover, between 2020 and 2027, the market Nano Biotechnology Market
Share, shall expand
at a rate of 10.0%, reveals MRFR.
COVID-19 Analysis
The COVID-19 pandemic has led to closure of
several business all over the world, with many operational facilities forced to
shut down in the wake of strict lockdowns being imposed by the government. The lockdown
posed several challenges to the healthcare sector, with manufacturing of medical
devices slowing down and imbalance in supply and demand gap for a variety of
essential healthcare products.
Furthermore, there were disruptions to the supply
chains for various medical supplies, causing a significant rift between the
supply and demand ratio and huge revenue losses for the manufacturers. However,
nanobiotechnology emerged as a credible solution, by accelerating the
development of vaccines. It is being used for developing new and highly
effective medicine formulations that have lower side effects. The technology is
also helping design new materials and tools to be used in healthcare,
electronics, energy generation, and biomaterials.
Renowned
Vendors
Nanobiotix (France), Nami Therapeutics
(US), Nanophase Technologies Corporation (US), Sigma-Aldrich (US), Ablynx
(Belgium), Nano Bridging Molecules SA (Switzerland), Celgene Corporation (US),
SkyePharma Pharmaceuticals (France), Dabur Pharma (India), XanTecBioanalytics
GmbH (Germany)
are listed in the report as some of the most affluent contenders in the global Nano Biotechnology Market Players.
Market
Segmentation
For presenting an
exhaustive outline of the global nano biotechnology Market Outlook, the MRFR
report has considered a few segments, namely application as well as therapeutics.
Major applications
of nano biotechnology are medical devices, pharmaceuticals, food and
agriculture, and medical research. The pharmaceutical segment has procured the
top spot in the market and shall continue to thrive backed by the rising
spending on R&D for advanced drugs to be used in the treatment of various chronic
diseases.
With respect to therapeutics,
the global nano biotechnology industry has been split into orthopedic
therapies, cardiac therapies, dental therapies, and others. The cardiac
therapies category is in the lead, thanks to the surging cases of cardiovascular
disorders all around the world.
Top Growth Boosters
& Impediments
Nano biotechnology’s commercial
applications in the biomedical field are primarily directed towards designing
advanced drug delivery systems, and this rising use of the technology is likely
to have a tremendous impact on the global market in the several years to follow.
Pharmaceutical and biotechnology sectors are and will remain the biggest end-users
of nano biotechnology. Drug delivery is one of the most crucial applications of
nano biotechnology, which is a primary reason for the robust market growth
worldwide. Other than addressing solubility-based challenges, nanobiotechnology
also provides intracellular delivery possibilities while enhancing the skin
penetration rate in multiple transdermal drug delivery cases. Another extremely
noteworthy application includes nonviral gene therapy vectors, which is proving
to be a huge growth booster in the global market.
Nano biotechnology has significant potential
to create innovative interface systems between multiple physical objects and
several living cells to facilitate connection between electronic devices with the
biological systems. Years of vigorous research and development with respect to nanobiotechnology
has now given way to synthesis of highly advanced nanofabricated systems as
well as devices that help treat various acute ailments. Microfabrication has
been gaining traction, used extensively for developing miniature biological
systems.
Regional Study
The nano biotechnology industry has been
regionally divided into Europe and North America along with MEA or Middle East
and Africa as well as APAC or Asia Pacific.
North America is more than likely to attain
the highest position in the global market, thanks to the large-scale spending
on R&D projects, as well as the well-developed research institutions focused
on product innovation. The strict government measures aimed at improving the healthcare
system, combined with the rising demand from numerous major end users could
also contribute to the market growth. Many of the companies in the region are investing
considerably in R&D of new products and technologies, with business
expansion being the big picture. Favorable business scenario in the region for biotechnology
and pharmaceutical manufacturers in view of the high success rates of clinical
trials and the surge in Food and Drug Administration (FDA) approvals.
Nanobiotechnology’s accelerated use in the neurology field has further
bolstered the market size in the United States.
The European market for nanobiotechnology is
not far behind, on account of the emergence of technologically innovative
products paired with the presence of robust R&D facilities. Government
assistance, substantial investments made by the manufacturers, and the extensive
use of cutting-edge technologies during manufacturing also propel the market
position in the region.
With that said, the fastest growth will be
seen by Asia Pacific, a region brimming with lucrative opportunities in the
form of rapidly improving healthcare infrastructure as well as the mounting
burden of chronic diseases like neurological and cardiovascular disorders. The
sizeable funds by the government for upgradation of the healthcare system offers
growth avenues to the industry firms.
Related Report-
Smart
Pills Market Research Report - Forecast to 2027
Vascular
Patches Market Research Report-Global Forecast till 2027
About US:
Market Research Future (MRFR) enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact us:
Market Research Future (part of Wantstats
Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment